LDGraft in Single Level Anterior Lumbar Interbody Fusion (ALIF)

Recruiting

Phase 1

Phase 2

LDGraft vs. AllograftLDGraft in Single Level Anterior Lumbar Interbody Fusion (ALIF)

Sponsor:

Locate Bio Pty Ltd

Code:

NCT06462729

Conditions

Degenerative Disc Disease

Lumbar Disc Disease

Spine Disease

Lumbar Spine Degeneration

Eligibility Criteria

Sex: All

Age: 22 - 70+

Healthy Volunteers: Not accepted

Interventions

LDGraft

Allograft Bone

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-02-08. This information was provided to ClinicalTrials.gov by Locate Bio Pty Ltd on 2026-01-28.